Table 3. Fatalities associated with... | American Society of Hematology

Table 3.

Fatalities associated with incompatible platelet transfusions reported to the US Food and Drug Administration from 2007 to 2017

Fiscal year	Patient ABO	Platelet ABO	Antibody titer
2015	B	A	Anti-B (1:2048)
2014	A	O	Anti-A (1:2048)
2014	AB	O*	Anti-A and anti-B (1:128)Anti-A and anti-B (1:128)
2014	AB	O*	Anti-A and anti-B (1:128)Anti-A and anti-B (1:128)
2012	A	O†	“High titer”Data not provided
2012	A	O†	“High titer”Data not provided
2011	A‡	O	Anti-A 1:512 for IgM and 1:2048 for IgG²⁵
2008	B‡	O	“High titer”Data not provided.

Fiscal year	Patient ABO	Platelet ABO	Antibody titer
2015	B	A	Anti-B (1:2048)
2014	A	O	Anti-A (1:2048)
2014	AB	O*	Anti-A and anti-B (1:128)Anti-A and anti-B (1:128)
2014	AB	O*	Anti-A and anti-B (1:128)Anti-A and anti-B (1:128)
2012	A	O†	“High titer”Data not provided
2012	A	O†	“High titer”Data not provided
2011	A‡	O	Anti-A 1:512 for IgM and 1:2048 for IgG²⁵
2008	B‡	O	“High titer”Data not provided.

IgG, immunoglobulin G; IgM, immunoglobulin M.

Recipient received 2 units of group O platelets from the same donor.

Recipient received 2 units of group O platelets from 2 different donors.

Recipient’s blood group recently changed following ABO-mismatched hematopoietic stem cell transplant.